Kronos Bio

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Kronos Bio and other ETFs, options, and stocks.

About KRON

Kronos Bio, Inc. is a clinical-stage biopharmaceutical, engages in the provision of discovery and development of novel cancer therapeutics products. Its pipeline includes hematologic malignancies, prostate cancer, MYC-driven cancers, and small cell/neuroendocrine cancers. 

CEO
Norbert W. Bischofberger
CEONorbert W. Bischofberger
Employees
96
Employees96
Headquarters
San Mateo, California
HeadquartersSan Mateo, California
Founded
2017
Founded2017
Employees
96
Employees96

KRON Key Statistics

Market cap
181.66M
Market cap181.66M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
174.65K
Average volume174.65K
High today
$3.27
High today$3.27
Low today
$3.18
Low today$3.18
Open price
$3.20
Open price$3.20
Volume
116.00K
Volume116.00K
52 Week high
$20.97
52 Week high$20.97
52 Week low
$2.96
52 Week low$2.96

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

KRON Earnings

-$1.13
-$0.75
-$0.38
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.